Glioblastoma is a dangerous brain tumor known for its fast growth and resistance to standard treatments. Research are constantly underway to identify new management strategies, and website recently, a new biomarker named LCA168 has emerged as a potential focus for glioblastoma treatment. LCA168 is a protein that is overexpressed in GBM cells compa